Professor Fidelma Dunne appointed Interim Director of University of Galway Institute for Clinical Trials.
World-leading research academic Professor Fidelma Dunne has been appointed Interim Director of the Institute for Clinical Trials at University of Galway. Professor Dunne has an extensive background in clinical trial management and is ranked number 1 in Ireland and number 6 in the world for her research into gestational diabetes. The University has also announced John Kilmartin, former Vice-President of Regulatory Affairs at Medtronic and an independent medtech regulatory expert, joins the Institute for Clinical Trials as Adjunct Professor. Mr Kilmartin has more than 30 years’ experience in the medtech industry, with a particular focus on the emerging regulatory and clinical frameworks in Europe.
Professor Martin O’Donnell, Dean of the College of Medicine, Nursing and Health Sciences and Consultant Geriatrician at Saolta University Health Care Group, said: “We are honoured to have both Professor Fidelma Dunne and Mr John Kilmartin join the Institute for Clinical Trials. Their combined expertise in clinical trials, medical research and regulatory affairs will significantly contribute to our mission of advancing impactful clinical research. They will help to advance our clinical research goals and will make meaningful contributions to healthcare outcomes.”
Professor Dunne said: “Clinical trials in new medicines and devices are vital to improving the health of people living in Ireland and worldwide. Improving health also has economic and societal benefits. Engaging in clinical trials allows patients in Ireland to receive new medicines and devices early. We have a track record of designing and delivering impactful clinical trials at University of Galway and I am delighted to lead the Institute for Clinical Trials which will have a pivotal role in further enhancing the clinical research landscape in Ireland.”
Mr Kilmartin said: “The medtech industry is of huge importance to Ireland and Europe for the benefit of our patients, health systems and society. I believe that the Institute for Clinical Trials at University of Galway can play a key role in helping to support innovation in medtech by strategically targeting barriers within the Irish ecosystem. It aims to strengthen and further promote growth in the medtech sector, expand treatment options for patients and ultimately contribute to the advancement of healthcare on a broader scale.”